Reassuringly, the same association between MTA1 and AKT/mTOR/4EBP1 was recently reported in endometrial cancer, in which miR-30c/MTA1 axes regulated cell proliferation, migration, and invasion via AKT/mTOR signaling defining MTA1 as a therapeutic target in endometrial cancer [47]. Here, MTOR is linked to endometrial cancer.